Safety-Related Labeling Changes
Stevens-Johnson syndrome , toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms and acute generalized exanthematous pustulosis
Trade Name
Takepron
Updated Section
4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects
Month
Mar,2023